Browsing Tag
National Institute on Aging
2 posts
Lighthouse Pharmaceuticals secures $49.2mn NIA grant to advance Phase 2 trial targeting P. gingivalis-positive Alzheimer’s disease
Lighthouse Pharmaceuticals wins $49.2mn NIA grant to trial LHP588, a microbial-targeted Alzheimer’s therapy. Discover its impact on research and patients.
RevBio secures NIH grant for game-changing TETRANITE Technology
RevBio, Inc., revealed that it has secured a substantial grant of up to $3.4 million, to be disbursed…